Prospects of RNAi and microRNA-based therapies for hepatitis C.
about
Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesDisturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.[RNA interference library research progress and its application in cancer research].Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses.AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?
P2860
Prospects of RNAi and microRNA-based therapies for hepatitis C.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospects of RNAi and microRNA-based therapies for hepatitis C.
@en
Prospects of RNAi and microRNA-based therapies for hepatitis C.
@nl
type
label
Prospects of RNAi and microRNA-based therapies for hepatitis C.
@en
Prospects of RNAi and microRNA-based therapies for hepatitis C.
@nl
prefLabel
Prospects of RNAi and microRNA-based therapies for hepatitis C.
@en
Prospects of RNAi and microRNA-based therapies for hepatitis C.
@nl
P2860
P1476
Prospects of RNAi and microRNA-based therapies for hepatitis C
@en
P2093
Harry L A Janssen
Hugo W Tilanus
P2860
P304
P356
10.1517/14712590902989970
P407
P577
2009-06-01T00:00:00Z